You’re invited: Biologics and Brews—Princeton Edition
You choose—integrated or standalone CDMO/CRO services. Either way, the drinks are on us.
Thermo Fisher Scientific invites you to Biologics and Brews—our most popular networking event for biotech and pharma professionals, now making its second exclusive stop on the East Coast.
Graciously hosted by BioLabs, this happy hour will feature yummy bites and brews to please every palate, whether you’re a drug developer foodie or a beer enthusiast who works in biologics.
Come explore our end-to-end offerings for:
- Drug substance and product development
- Clinical trial supply chain solutions
- Cold chain storage and distribution
As a special bonus, two members of our Scientific and Technical Affairs team will be joining us:
Dr. Annie Cruz, Senior Scientific and Technical Affairs Manager, Drug Substance Development and Manufacturing, 14+ years of experience
“I like to think my work helps ensure the biologics we make meet health standards so they’re safe and effective—because bringing life-saving medicines to patients is what inspires me most.”
Christy Eatmon, Senior Scientific and Technical Affairs Manager, Drug Product and Fill-Finish, 20+ years of experience
“I specialize in process engineering, product development, and aseptic manufacturing and filling. My passion for innovative formulation development and new advances in injectable drug delivery has made my career especially rewarding.”
Meet with Annie and/or Christy over drinks or in a pre-scheduled meeting to discuss your needs or learn more from the tips and tricks they’ve gained throughout their roles in the pharmaceutical industry.
What’s on tap (besides the beer)?
Our experts will deliver a short, punchy presentation on the biggest challenges they’ve encountered at every phase of biologics development—and the smart, proven strategies that helped solve them.
Come prepared with your questions and get ready for some realness.
Get a sneak peek of our solutions
We’ll also discuss our novel Path to IND for biologics platform, which helps biotech drug developers like yourself move from DNA to first-in-human Phase I clinical trials in as little as nine months.*
Sound like your idea of a good time?
Terms and Conditions: Titer levels provided are estimates based on third-party results and may vary depending on molecule type or other factors. Timelines from DNA to drug product and the start of clinical trials for all Path to IND for biologics options may vary depending on molecule type or other factors and are estimates to be finalized once third-party cell line development dates are available and confirmed. The 9-month timeline may incur additional risk.
Continuing education for the pharma industry
Follow us on social for event updates
We look forward to seeing you soon